Research Studies
Published research on HBOT for Anti-Aging & Longevity
← Browse all conditions in the PubMed Research LibraryHyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. (opens PubMed in a new tab)
Hachmo Y; Hadanny A; Abu Hamed R; Daniel-Kotovsky M; Catalogna M; Fishlev G; Lang E; Polak N; Doenyas K; Friedman M; Zemel Y; Bechor Y; Efrati S — Aging
Plain English Summary
The study measured changes in telomere length and senescent immune cells in healthy older adults receiving HBOT.
Limitations & context: These are blood-cell biomarkers, not proof of reversed aging, longer lifespan, or fewer age-related diseases. There was no untreated randomized control group.
Physical enhancement of older adults using hyperbaric oxygen: a randomized controlled trial. (opens PubMed in a new tab)
Hadanny A; Sasson E; Copel L; Daniel-Kotovsky M; Yaakobi E; Lang E; Fishlev G; Polak N; Friedman M; Doenyas K; Finci S; Zemel Y; Bechor Y; Efrati S — BMC geriatrics
Plain English Summary
Older adults receiving HBOT improved on measures of exercise capacity and cardiac perfusion compared with controls.
Limitations & context: Physical-performance outcomes do not establish increased lifespan or reversal of aging. Findings require confirmation in broader populations.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.